Dr. Shafaee on the PERSEPHONE Trial in Early-Stage HER2+ Breast Cancer
July 19th 2018Maryam Nemati Shafaee, MD, assistant professor, Duncan Cancer Center, Lester & Sue Smith Breast Cancer, Baylor College of Medicine, discusses the PERSEPHONE trial in women with early-stage HER2-positive breast cancer.
Read More